CG3.BE: Summary for CELGENE CORP. DL-,01 - Yahoo Finance

UK Markets closed


Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
113.16-0.40 (-0.35%)
At close: 8:08AM CET
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close113.56
Bid108.26 x 11000
Ask108.54 x 10900
Day's range113.16 - 113.16
52-week range87.60 - 116.80
Avg. volume15
Market capN/A
PE ratio (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzingayesterday

    Orphan Drugs Among 2015's Top 10 Best-Selling Medications

    Orphan drugs , drugs intended to prevent, diagnose or treat rare diseases/disorders, are huge sellers for the pharmaceutical industry. NPR, citing data from EvaluatePharma, noted that seven of the 10 best-selling ...

  • Market Realistyesterday

    Health Care Sector Fell amid Donald Trump’s Comments

    After closing last week almost unchanged, the health care sector started the week on a weaker note. On Tuesday, the S&P 500 Health Care sector fell 0.45%.

  • Is Donald Trump Celgene's Biggest Risk in 2017?
    Motley Fool2 days ago

    Is Donald Trump Celgene's Biggest Risk in 2017?

    Celgene's high-priced medicine has helped the drugmaker deliver investors significant growth, but growing pushback on pricing by Donald Trump this year could make the company's shares riskier than they've been in that past.